Jump to ContentJump to Main Navigation
The Genealogy of a GenePatents, HIV/AIDS, and Race$
Users without a subscription are not able to see the full content.

Myles W. Jackson

Print publication date: 2015

Print ISBN-13: 9780262028660

Published to MIT Press Scholarship Online: September 2015

DOI: 10.7551/mitpress/9780262028660.001.0001

Show Summary Details
Page of

PRINTED FROM MIT PRESS SCHOLARSHIP ONLINE (www.mitpress.universitypressscholarship.com). (c) Copyright The MIT Press, 2022. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in MITSO for personal use.date: 29 May 2022

The European Response to the CCR5 Patent

The European Response to the CCR5 Patent

(p.88) (p.89) 5 The European Response to the CCR5 Patent
The Genealogy of a Gene

Myles W. Jackson

The MIT Press

This chapter discusses the patenting of the CCR5 gene in Europe. It compares and contrasts the practices of the United States Patent and Trademark Office (USPTO) with the European Patent Office (EPO) with regard to gene patenting. It also focuses on the anatomy of opposing a European patent and offers an informative glimpse into the world of patent litigation. A contrast between the USPTO and the EPO is informative since it points out that there are alternatives: questions of human value are embedded differently in various legal regimes. The situation in which the US finds itself is not inevitable.

Keywords:   European Patent Office, United States Patent and Trademark Office, gene patenting in Europe, patent litigation, Big Pharma, Euroscreen

MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.